Dr. Reddy’s Laboratories informs about media release
Dr. Reddy’s Laboratories has informed that it enclosed a Press Release titled “Dr. Reddy’s Laboratories announces launch of India’s first DCGI-approved Semaglutide injection ‘Obeda®’ for Type 2 Diabetes.’
The above information is a part of company’s filings submitted to BSE.
